← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2015Last known activity
Apr 15, 2023
Timeline
2000s
- Jan 1, 2005
Linical Co., Ltd.— Founded
2010s
- Jul 1, 2018
Accelovance— Acquired
Drugs by trial phase (43 distinct, 33 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (1 own, 2 via acquisition)
Phase 2 (5 own, 15 via acquisition)
Phase 1 (0 own, 12 via acquisition)
Indications
Subsidiaries (1 direct, 2 total across the full acquisition tree)
Recent trials (11)
- NCT05826990CollaboratorPhase 2Apr 15, 2023
- NCT05569746CollaboratorPhase 2Sep 28, 2022
- NCT05164198CollaboratorPhase 4Jan 15, 2022
- NCT04812431CollaboratorPhase 1/Phase 2Sep 30, 2021
- NCT03217409CollaboratorPhase 4Aug 10, 2017
- NCT04763096Lead sponsorPhase 4Nov 30, 2016
- NCT02968160CollaboratorPhase 4Oct 1, 2016
- NCT03423225CollaboratorPhase 4Mar 22, 2016
- NCT02596321CollaboratorPhase 3Oct 1, 2015
- NCT04761731Lead sponsorPhase 4Jul 31, 2015
- NCT02415959CollaboratorPhase 2Mar 1, 2015
Details
- Founded
- Seoul, KR Jan 1, 2005
- Last known activity
- Apr 15, 2023
Notes
CRO --- Notes from Linical Korea: CRO --- --- Pre-folding founded info: 2005-06-01 Yodogawa None Japan https://www.crunchbase.com/organization/linical#section-overview ---